Finland· FI-REL-REL10431
Cetrotide
A cetrorelix product containing cetrorelix acetate, registered in Finland by Merck Europe B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cetrorelix is registered in 15 of 19 countries.
Countries holding a registration under ATC H01CC02 (cetrorelix), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Cetrorelix · ATC H01CC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cetrorelix costs, country by country.
Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cetrorelix · price per daily dose (0.25 mg)
USD · FX 28 Sept 2026
- ES Spain$40.95
The record
At a glance
Fimea (Finland)- Active substance
- Cetrorelix acetate
- Manufacturer
- Merck Europe B.V.
- Country
- Finland (FI)
- ATC code
- H01CC02
- ATC class
- Cetrorelix
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cetrorelix in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCETRORELIX EDEST 0,25 MG POLVO PARA SOLUCION INYECTABLEIntas Third Party Sales 2005 S.L.
- CzechiaCETROTIDEMerck Europe B.V., Amsterdam
- IrelandCetrotide 0.25 mg powder and solvent for solution for injectionMerck Europe B.V.
- SwitzerlandCetrorelix Leman 0,25 mg, poudre pour solution injectableLeman SKL SA
- BelgiumCetrotide 0.25 mgMerck Europe
- FranceCETROTIDE 0,25 mg, poudre et solvant pour solution injectableMERCK EUROPE (PAYS-BAS)
- United KingdomCetrotide 250microgram powder and solvent for solution for injection vialsMerck Serono Ltd
- NetherlandsCetrotide 0,25 mg, poeder voor oplossing voor injectieMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Ceziboe
- Czechia · Cetrorelix Sun, Ceziboe
- Germany · Ceziboe
- Spain · Ceziboe Sun
- France · Ceziboe
- United Kingdom (Northern Ireland) · Ceziboe
- Greece · Ceziboe
- Hungary · Ceziboe
- Ireland · Ceziboe
- Iceland · Cetrotide
- Italy · Ceziboe
- Liechtenstein · Cetrotide
- Netherlands · Ceziboe
- Norway · Cetrotide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7d172b5-59c1-4bd1-aea3-aa6502e06e7a GET /v1/drugs/d7d172b5-59c1-4bd1-aea3-aa6502e06e7a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.25",
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Ihon alle",
"ddd_unit": "mg",
"strength": "0.25 mg",
"atc_label": "setroreliksi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/99/100/001-002",
"fimea_rel_id": "REL10431",
"authorised_at": "1999-04-13"
}See everything about cetrorelix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.